AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032 ...

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Society / One key revelation in the wide correspondence of the late pedophile: the rich and powerful just aren’t all that ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...

Fragments of DNA from long-extinct human relatives still circulate in modern genomes, and in some cases they do more than linger. They actively shape how people survive in extreme environments. The ...

Infleqtion has been selected to advance to Phase 3 of the Q4Bio Challenge, a global program demonstrating quantum-enabled solutions for human health.

Extracting and analyzing relevant medical information from large-scale databases such as biobanks poses considerable challenges. To exploit such "big data," attempts have focused on large sampling ...

Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematologic disorders, particularly when matched donors are ...

An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis method that can accurately classify brain tumors using genetic ...